Interleukin-6 (IL-6) inhibitors as therapeutic agents for coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis

• Asıl Yazarlar: Rizaldy Taslim Pinzon (Yazar), Vincent Ongko Wijaya (Yazar), Ranbebasa Bijak Buana (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Elsevier, 2021-08-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Introduction: Preliminary studies showed that coronavirus disease 2019 (COVID-19) disrupts body immune system, including dysregulation of cytokine interleukin-6 (IL-6). IL-6 inhibitors agents have been used as treatment options for COVID-19, yet their benefit as therapeutic agents remains unclear. O...